Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of FASTK mRNA | affects expression | 21346803
|
C027576 |
4-hydroxy-2-nonenal |
4-hydroxy-2-nonenal results in decreased expression of FASTK mRNA | decreases expression | 12419474
|
C002202 |
4-oxoretinoic acid |
4-oxoretinoic acid results in decreased expression of FASTK mRNA | decreases expression | 15982314
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of FASTK mRNA | affects expression | 17562736
|
C103303 |
alitretinoin |
alitretinoin results in decreased expression of FASTK mRNA | decreases expression | 15982314
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of FASTK mRNA | decreases expression | 15336504 12419474
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FASTK mRNA | affects cotreatment|increases expression | 17942748
|
D015474 |
Isotretinoin |
Isotretinoin results in decreased expression of FASTK mRNA | decreases expression | 15982314
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of FASTK mRNA | decreases expression | 12760830
|
C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of FASTK mRNA | affects expression | 17440010
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FASTK mRNA | affects cotreatment|increases expression | 17942748
|
D014212 |
Tretinoin |
Tretinoin metabolite results in decreased expression of FASTK mRNA | decreases expression | 15982314
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of FASTK mRNA | decreases expression | 15982314
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Isotretinoin |
9.22 | 18769834 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
9.22 | 11752688 14514962 15322242 |
MESH:D000015 |
Abnormalities, Multiple |
|
Isotretinoin |
5.09 | 18769834 |
MESH:D017486 |
Acneiform Eruptions |
|
Isotretinoin |
6.46 | 16232082 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
12.59 | 17505938 |
MESH:D000152 |
Acne Vulgaris |
|
Isotretinoin |
12.59 | 16185265 18769834 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.83 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.53 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.87 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.08 | 17306315 16712894 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.70 | 15955085 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
4-hydroxy-2-nonenal |
4.16 | 10965797 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.05 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.02 | 10982225 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.60 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
7.42 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
7.42 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.29 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.37 | 16456186 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.41 | 18445737 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.53 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.31 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
9.31 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.96 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.83 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
1.95 | 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.95 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
1.95 | 16873071 16443354 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.74 | 16813970 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.89 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.33 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
6.69 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
6.69 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
6.69 | 16507464 15276417 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
6.69 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Isotretinoin |
7.87 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
7.87 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
7.87 | 16051514 16096774 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.42 | 16120746 18670907 18850075 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
7.43 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
7.43 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
6.99 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
6.99 | 20056578 19524636 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.74 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.26 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.95 | 17110522 17681005 17333356 16105132 11677210 16919318 15861022 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.33 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.90 | 15668235 8697196 16354765 15340226 12621046 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.90 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.84 | 17035595 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Isotretinoin |
3.96 | 18769834 9879862 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.96 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.96 | 9142499 17551590 9664655 10589399 14991402 16925845 9224671 9211117 9125849 8800419 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.16 | 18551238 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.69 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.29 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
6.29 | 19164858 11743745 10774834 11834606 14550746 16227642 19923254 19085960 12594235 12705907 12153990 16781746 2444490 14725611 12540782 15968718 16393943 16081117 11529661 19416960 17562736 19739265 19370779 11287661 16485898 11461765 11739529 17906064 10663392 18071297 11421492 14986274 17522070 16177239 12958197 18713872 15619225 10915739 12392966 16109766 19420014 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.29 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.27 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.84 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.48 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
12.53 | 15322242 18230668 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
12.53 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.31 | 12538720 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.18 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.12 | 9294722 10568697 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
9.11 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
9.11 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
2.92 | 15345470 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.59 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.09 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
9.09 | 17994277 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.85 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.83 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.07 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.77 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.26 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.33 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.72 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.72 | 9664655 14991402 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.44 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.03 | 12621046 15340226 16120746 |
MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
5.92 | 17440010 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.25 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.22 | 16959395 8697196 18606429 15340226 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
7.92 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
7.92 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.71 | 16778211 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.94 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.95 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.58 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.88 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.88 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.91 | 12200463 12878042 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.90 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
10.30 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
10.30 | 15992940 17551590 |
MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
5.79 | 16144296 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
6.16 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
6.16 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
3.07 | 16705839 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.82 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.81 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.09 | 16294345 19850784 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.22 | 9834237 17649720 17712046 19225113 17368321 16891316 12679006 17107899 17506722 17339181 16140955 17301526 16766008 16788101 15748426 17361223 16331271 17294898 17217047 16935935 19642359 19035177 19029980 19075265 16823087 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.38 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.33 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
2.33 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.65 | 16611625 19460945 11587558 16610002 12587719 19014921 12969438 19784758 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.34 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
7.62 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
7.62 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.62 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
5.95 | 6135515 2876784 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.95 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.24 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
5.03 | 16413115 |
MESH:D008175 |
Lung Neoplasms |
|
Isotretinoin |
5.03 | 15899809 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
5.03 | 19931552 17077188 15276417 17306315 16712894 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
5.03 | 19555203 11884234 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.82 | 17453147 |
MESH:D008545 |
Melanoma |
|
Isotretinoin |
5.36 | 17237267 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
5.36 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
5.36 | 16752155 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.71 | 19513568 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.56 | 16940565 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.14 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.11 | 12213967 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.01 | 18551238 7678174 |
MESH:D009369 |
Neoplasms |
|
alitretinoin |
8.71 | 16946489 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
8.71 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
8.71 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.80 | 20056578 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.94 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
9.94 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
7.54 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
7.54 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Isotretinoin |
4.09 | 17368321 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.96 | 18514411 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.53 | 16049721 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
4.99 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
4.99 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
6.89 | 16870215 |
MESH:D010146 |
Pain |
|
Tretinoin |
6.89 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.50 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.80 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.42 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4-hydroxy-2-nonenal |
5.68 | 11550810 |
MESH:D017499 |
Porokeratosis |
|
alitretinoin |
6.18 | 16144296 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.69 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Isotretinoin |
10.37 | 18769834 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
10.37 | 11118676 11896295 11399792 11222880 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.28 | 16039940 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.72 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.47 | 15861022 16919318 |
MESH:D011596 |
Psychomotor Disorders |
|
Isotretinoin |
6.07 | 18769834 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.95 | 16723453 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.96 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.22 | 16116481 16283617 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.61 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
13.97 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
13.97 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
13.97 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
13.97 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.12 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.88 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.80 | 17261132 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.74 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.25 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.08 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.11 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.89 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.29 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.22 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
5.22 | 11723127 17306315 16452187 16712894 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.47 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.09 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
9.76 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
9.76 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.42 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.78 | 16752155 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.58 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.77 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.65 | 14671159 15869587 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.18 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.42 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.07 | 16287080 |